Nigellimine
CAS: 4594-02-9
Ref. 3D-EAA59402
| 1g | Descontinuado | ||
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado |
Informação sobre produto
Nome:
Nigellimine
Sinónimos:
- 1-Methyl-6,7-dimethoxyisoquinoline
- Isoquinoline, 6,7-Dimethoxy-1-Methyl-
- Isosalsolidine
- Nigellicimine
- 6,7-Dimethoxy-1-methylisoquinoline
Descrição:
Nigellimine is a medicinal compound that has been shown to have potent anti-cancer properties. It is a kinase inhibitor that targets specific kinases involved in cancer cell proliferation and survival. Nigellimine is an analog of a compound found in Chinese black seed, and it has been shown to induce apoptosis (programmed cell death) in tumor cells. This compound has also demonstrated anticancer activity in animal studies, inhibiting the growth of cancer cells and reducing tumor size. Nigellimine is excreted in urine and has been shown to be safe for human consumption. Its potential as an anticancer therapy makes it a promising candidate for further research and development.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
203.24 g/mol
Fórmula:
C12H13NO2
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
